February 21, 2021

Immunosuppressive Drugs Market Size 2021-2026 on Going Trends By Development History, Regional Overview, Share Estimation, Revenue, and Business Prospect,

(MENAFN - America News Hour) Market Forecast The Global Immunosuppressive Drugs Market is expected to cross USD 1.39 Billion by 2025 at a CAGR of 4.63%. Immunosuppressants are generally used post

by Transplant News

Kidney Transplants

Medication

February 6, 2021

Is it OK to Cut Back on Prednisone After Kidney Transplant?

Long-range post-kidney transplant corticosteroids may not be necessary for most patients, researchers reported. In new long-term data (median 15.8 years) on 191 patients who withdrew from corticosteroids 7 days after undergoing

by Transplant News

Medication

Stem Cell Transplants

January 20, 2021

Narsoplimab Under Review for Stem Cell Transplant-Associated Thrombotic Microangiopathy

The Food and Drug Administration (FDA) has accepted for filing and granted Priority Review to narsoplimab (Omeros Corporation) for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA). Narsoplimab is

January 5, 2021

Tonix Pharmaceuticals and Massachusetts General Hospital (MGH) Enter into Research Collaboration on Tonix’s Third Generation anti-CD40-Ligand Monoclonal Antibody, TNX-1500, for the Treatment and Prevention of Kidney Transplant Rejection

CHATHAM, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the signing of a second research

by Transplant News

Innovation

Medication

Stem Cell Transplants

Tech & Industry

November 6, 2020

Magenta Therapeutics Announces Multiple Presentations Across Stem Cell Transplant Portfolio at The American Society of Hematology (ASH) Annual Meeting

Transplant News Sharing // News from Source www.businesswire.com CAMBRIDGE, Mass.--(BUSINESS WIRE)--Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplant to

Organ Transplant Technology

November 1, 2020

Antifungal Prophylaxis Reduces Mortality in Lung Transplantation

Transplant News Sharing // News from Source www.pulmonologyadvisor.com Lung transplant recipients who were given antifungal medications prophylactically to prevent invasive fungal infections had lower rates of mortality, according to the results

Intestinal Transplants

Pancreatic Transplants

Pediatric Transplant

Stem Cell Transplants

Tech & Industry

October 28, 2020

TFF Pharmaceuticals – Game-Changing Drug Reformulation Technology (NASDAQ:TFFP)

Transplant News Sharing // News from Source seekingalpha.com TFF Pharma (TFFP) is a small cap pharmaceutical company with an extraordinary amount of irons in the fire. With a novel drug-formulation technology,

by Transplant News

Bone Marrow Transplants

Business

Health

Heart Transplants

Intestinal Transplants

Pancreatic Transplants

Stem Cell Transplants

Tech & Industry

October 27, 2020

Solid Organ Transplant Immunosuppressant Industry Market Size, Global Analytical Overview, Key Players, Regional Demand, Trends and Forecast To 2026 – Zenit News

Transplant News Sharing // News from Source zenitnews.com A recent market research report added to repository of Credible Markets is an in-depth analysis of “Global Solid Organ Transplant Immunosuppressant Industry Market”.

October 23, 2020

New Data Offers Insights on Treatment with KRYSTEXXA® (pegloticase injection) Among Kidney Transplant Patients for the Management of Uncontrolled Gout

Transplant News Sharing // News from Source www.biospace.com There is a strong correlation between gout and chronic kidney disease.1 Reduced kidney function may hinder effective clearance of urate-lowering therapies,2 creating additional

October 23, 2020

Envarsus® PA Once-daily Immunosuppressive Therapy for Kidney and Liver Transplant Patients is Now Reimbursed in Ontario, Quebec, Manitoba and Saskatchewan Français

Transplant News Sharing // News from Source www.newswire.ca MONTREAL, Oct. 22, 2020 /CNW/ -- Paladin Labs Inc., a subsidiary of Endo International plc (NASDAQ: ENDP), announced today that Ontario, Quebec, Manitoba and

by Transplant News

LOAD MORE STORIES